Cencora Inc.
American pharmaceutical distribution company specializing in drug distribution and healthcare solutions, formerly known as AmerisourceBergen.
Company Type
public
Founded
2001
Headquarters
Conshohocken, Pennsylvania, USA
Stock
NYSE: COR
About Cencora Inc.
What does Cencora do?
Cencora distributes pharmaceutical products, including brand-name drugs, generic drugs, and specialty medications, to pharmacies, hospitals, physician offices, and other healthcare providers across the United States and internationally. The company also provides manufacturer services, patient support programs, specialty logistics, and veterinary pharmaceutical distribution through its subsidiaries.
Cencora distributes pharmaceutical products, including brand-name drugs, generic drugs, and specialty medications, to pharmacies, hospitals, physician offices, and other healthcare providers across the United States and internationally. The company also provides manufacturer services, patient support programs, specialty logistics, and veterinary pharmaceutical distribution through its subsidiaries.
Is Cencora publicly traded?
Yes, Cencora, Inc. trades on the New York Stock Exchange under ticker symbol COR. The company has no controlling shareholder, though Walgreens Boots Alliance holds approximately 15% of shares as the largest single investor.
Yes, Cencora, Inc. trades on the New York Stock Exchange under ticker symbol COR. The company has no controlling shareholder, though Walgreens Boots Alliance holds approximately 15% of shares as the largest single investor.
What is Cencora's annual revenue?
In fiscal year 2024 (ended September 30, 2024), Cencora reported revenue of $294.0 billion, a 12.1% increase from the prior fiscal year. The company is one of the largest companies in the United States by revenue.
In fiscal year 2024 (ended September 30, 2024), Cencora reported revenue of $294.0 billion, a 12.1% increase from the prior fiscal year. The company is one of the largest companies in the United States by revenue.
Why did AmerisourceBergen change its name to Cencora?
AmerisourceBergen changed its name to Cencora in August 2023 to reflect its evolution from a primarily domestic pharmaceutical distributor into a global healthcare solutions organization. The rebranding followed the 2021 acquisition of Alliance Healthcare, which significantly expanded the company's international operations, and was intended to signal the company's broader capabilities beyond traditional drug distribution.
AmerisourceBergen changed its name to Cencora in August 2023 to reflect its evolution from a primarily domestic pharmaceutical distributor into a global healthcare solutions organization. The rebranding followed the 2021 acquisition of Alliance Healthcare, which significantly expanded the company's international operations, and was intended to signal the company's broader capabilities beyond traditional drug distribution.
Who is Cencora's CEO?
Robert P. Mauch became President and CEO of Cencora on October 1, 2024, succeeding Steven H. Collis, who had served as CEO since 2011. Collis transitioned to the role of Executive Chairman.
Robert P. Mauch became President and CEO of Cencora on October 1, 2024, succeeding Steven H. Collis, who had served as CEO since 2011. Collis transitioned to the role of Executive Chairman.
What is Cencora's role in the opioid settlement?
Cencora, along with McKesson and Cardinal Health, reached a $21 billion settlement with U.S. states and local governments in 2022 to resolve claims that the three distributors failed to adequately monitor suspicious opioid orders. Cencora's share of the settlement is approximately $6.1 billion, to be paid over 18 years.
Cencora, along with McKesson and Cardinal Health, reached a $21 billion settlement with U.S. states and local governments in 2022 to resolve claims that the three distributors failed to adequately monitor suspicious opioid orders. Cencora's share of the settlement is approximately $6.1 billion, to be paid over 18 years.
History of Cencora Inc.
Cencora traces its origins to two predecessor companies with deep roots in pharmaceutical distribution. AmeriSource Health Corporation was formed in 1985 through the merger of Alco Standard's pharmaceutical distribution business and other regional distributors. Bergen Brunswig Corporation had roots dating to the early 20th century, tracing its lineage to Bergen Drug Company, founded in 1888 in New Jersey.
The two companies merged in August 2001 to create AmerisourceBergen Corporation, combining their complementary geographic footprints and customer bases to create one of the three largest pharmaceutical distributors in the United States. The merger was valued at approximately $2.2 billion and created a company with annual revenues exceeding $40 billion at the time.
Throughout the 2000s, AmerisourceBergen expanded its capabilities beyond basic drug distribution into specialty pharmaceuticals, which require more complex handling, storage, and patient support services than traditional medications. The company built out its specialty distribution capabilities through acquisitions and organic investment, positioning itself to benefit from the rapid growth of high-cost specialty drugs.
In 2012, AmerisourceBergen formed a strategic partnership with Walgreens, under which Walgreens would source a significant portion of its pharmaceutical products through AmerisourceBergen. The partnership was later extended and deepened, with Walgreens Boots Alliance eventually acquiring approximately 15% of AmerisourceBergen's shares, making it the company's largest single shareholder.
The company expanded internationally through the acquisition of PharMerica's oncology business and, more significantly, through the 2021 acquisition of Alliance Healthcare, a European pharmaceutical distribution and services company, for approximately $6.5 billion. The Alliance Healthcare acquisition significantly expanded Cencora's international presence, adding operations in the United Kingdom, France, Germany, Spain, Portugal, and other European markets.
Steven H. Collis, who had served as CEO since 2011, announced a leadership transition in March 2024. Robert P. Mauch, who had served as Chief Operating Officer, became President and CEO on October 1, 2024, while Collis transitioned to Executive Chairman.
In August 2023, the company officially changed its name from AmerisourceBergen to Cencora, reflecting its transformation into a broader healthcare solutions organization with significant international operations and expanded service capabilities beyond traditional drug distribution.
Brands Owned by Cencora Inc.
View all 8 brandsCencora Inc. owns 8 brands in our database. Showing featured brands below.
AmerisourceBergen
Owned by Cencora Inc.
American pharmaceutical distribution brand representing the legacy operations of Cencora Inc., formerly known as AmerisourceBergen Corporation, specializing in drug distribution services.
pharmaceutical-distributiondrug-distributionhealthcare-supply-chain
GoodRx
Owned by Cencora Inc.
American healthcare technology platform providing prescription drug price comparison, discount coupons, and telehealth services to help consumers find affordable healthcare options.
prescription-savingshealthcare-technologydrug-prices
Lash Group
Owned by Cencora Inc.
Patient support services company providing pharmaceutical patient assistance programs, enrollment services, and healthcare support owned by Cencora.
patient-supportpharmaceutical-assistancehealthcare-services
MWI Animal Health
Owned by Cencora Inc.
Animal health pharmaceutical and supply distributor providing veterinary medications, medical supplies, and technology solutions to veterinary clinics and animal healthcare providers owned by Cencora.
animal-healthveterinary-suppliespharmaceutical-distribution
OneOncology
Owned by Cencora Inc.
Physician-led community oncology platform providing practice management, clinical support, and healthcare solutions to independent oncology practices owned by Cencora.
oncologycommunity-cancer-carepractice-management
Retina Consultants of America
Owned by Cencora Inc.
Leading retina specialist management services organization providing practice management and clinical support to retina specialists and ophthalmology practices owned by Cencora.
ophthalmologyretina-specialistspractice-management
Shop Cencora Inc. Brands
Disclosure: We may earn commission from purchases
Stock Information
Cencora Inc. Ownership: Pros & Cons
Advantages
- +One of three dominant U.S. pharmaceutical distributors, distributing approximately one-third of all U.S. pharmaceutical products
- +FY2024 revenue of $294.0 billion demonstrates the scale and essential nature of the business
- +Alliance Healthcare acquisition provides significant international diversification and growth platform
- +Specialty pharmaceutical capabilities position the company to benefit from continued growth in high-cost biologics and oncology drugs
- +Long-term commercial partnership with Walgreens Boots Alliance provides revenue stability
Considerations
- -Opioid settlement of approximately $6.1 billion represents a significant multi-year financial obligation
- -Thin distribution margins mean profitability is modest relative to revenue scale
- -Dependence on pharmaceutical price inflation as a revenue driver creates exposure to drug pricing reform
- -Walgreens Boots Alliance's financial difficulties could affect the commercial relationship and Cencora's revenue
- -Regulatory scrutiny of pharmaceutical distribution practices remains elevated following the opioid settlement
Frequently Asked Questions About Cencora Inc.
What does Cencora do?
Cencora distributes pharmaceutical products, including brand-name drugs, generic drugs, and specialty medications, to pharmacies, hospitals, physician offices, and other healthcare providers across the United States and internationally. The company also provides manufacturer services, patient support programs, specialty logistics, and veterinary pharmaceutical distribution through its subsidiaries.
Is Cencora publicly traded?
Yes, Cencora, Inc. trades on the New York Stock Exchange under ticker symbol COR. The company has no controlling shareholder, though Walgreens Boots Alliance holds approximately 15% of shares as the largest single investor.
What is Cencora's annual revenue?
In fiscal year 2024 (ended September 30, 2024), Cencora reported revenue of $294.0 billion, a 12.1% increase from the prior fiscal year. The company is one of the largest companies in the United States by revenue.
Why did AmerisourceBergen change its name to Cencora?
AmerisourceBergen changed its name to Cencora in August 2023 to reflect its evolution from a primarily domestic pharmaceutical distributor into a global healthcare solutions organization. The rebranding followed the 2021 acquisition of Alliance Healthcare, which significantly expanded the company's international operations, and was intended to signal the company's broader capabilities beyond traditional drug distribution.
Who is Cencora's CEO?
Robert P. Mauch became President and CEO of Cencora on October 1, 2024, succeeding Steven H. Collis, who had served as CEO since 2011. Collis transitioned to the role of Executive Chairman.
What is Cencora's role in the opioid settlement?
Cencora, along with McKesson and Cardinal Health, reached a $21 billion settlement with U.S. states and local governments in 2022 to resolve claims that the three distributors failed to adequately monitor suspicious opioid orders. Cencora's share of the settlement is approximately $6.1 billion, to be paid over 18 years.
Jobs at Cencora Inc.
Latest News About Cencora Inc.
Related Articles About Cencora Inc.
View more articles
News & Updates
Monthly M&A Roundup: February 2026 Brand Ownership Changes
From Keurig Dr Pepper's planned split to the Netflix-WBD saga, here is every major brand ownership change and deal in February 2026.
Who Brands StaffFeb 12, 2026
m-and-a-roundupacquisitionsnews
Industry Analysis
The Most Acquired Categories: Tech vs CPG vs Pharma
Which industries see the most brand acquisitions? We compared technology, consumer goods, and pharmaceuticals to find out where the most M&A activity happens and why.
Who Brands StaffFeb 11, 2026
acquisitionsindustry-analysistechnology
Consumer Education
The Truth About 'Made in America' Brand Claims
Many brands market themselves as American-made. But what does that actually mean when the parent company is foreign, the parts come from overseas, and 'assembled in USA' is not the same as 'made in USA'?
Who Brands StaffFeb 11, 2026
made-in-americaconsumer-educationbrand-claims